Werner Kroll
Chief Tech/Sci/R&D Officer bij QUIDELORTHO CORPORATION
Vermogen: 2 M $ op 31-03-2024
Profiel
Werner Kroll is Senior Vice President-Research & Development bij Quidel Corp. Dr. Kroll zit ook in de raad van bestuur van de European Personalised Medicine Association. Dr. Kroll was voordien VP & Head-Research & Innovation bij Novartis Institutes for Biomedical Research, Inc. Dr. Kroll behaalde een doctoraat aan de Philipps Universiteit van Marburg.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
QUIDELORTHO CORPORATION
0.05% | 28-03-2024 | 35 781 ( 0.05% ) | 2 M $ | 31-03-2024 |
Actieve functies van Werner Kroll
Bedrijven | Functie | Begin |
---|---|---|
QUIDELORTHO CORPORATION | Chief Tech/Sci/R&D Officer | - |
European Personalised Medicine Association | Director/Board Member | - |
Eerdere bekende functies van Werner Kroll
Bedrijven | Functie | Einde |
---|---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01-01-2022 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Opleiding van Werner Kroll
Philipps University of Marburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
QUIDELORTHO CORPORATION | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
European Personalised Medicine Association |